Regulation & law · 16/11/2005Updated: 10/17/2026 · 1 min read

Patent Licensing Opportunities for Bacterial Superantigen Vaccines Explored

The U.S. Patent and Trademark Office (USPTO) has announced the availability of licensing options for U.S. patents and patent applications related to bacterial superantigen vaccines, allowing companies to explore non-exclusive, exclusive, or partially exclusive licensing agreements.